Literature DB >> 4035304

Symptomatic and neuropsychological components of defect states.

R M Bilder, S Mukherjee, R O Rieder, A K Pandurangi.   

Abstract

The distinction between positive and negative symptoms has gained prominence in schizophrenia research, but the construct has not been unequivocally validated. The authors report preliminary findings of investigations in which symptomatic and neuropsychological assessments were conducted in a sample of 32 chronic schizophrenic inpatients. Three distinct clusters of symptoms were identified in correlative analyses. One cluster of symptoms (alogia, attentional impairment, positive formal though disorder, and bizarre behavior) appeared to reflect primarily a disorganization of though independent of current definitions of the positive/negative symptom construct. A second cluster of symptoms (affective flattening, avolition/apathy, and anhedonia) appeared to reflect predominantly blunting of affect and volition. A third cluster (delusions, hallucinations, and "breadth of psychosis") seemed to represent only the florid psychotic features. The first and (to a lesser extent) second clusters of symptoms were selectively associated with neuropsychological impairment. The patterns of neuropsychological deficits correlated with the first cluster of symptoms appeared to be consistent with a process characterized by failure in the development of a normal repertoire of cognitive abilities. It is suggested that the "defect state" may not be a monothetic construct, and that within the domain of "type II" schizophrenia, disturbances of thought may be distinguished from those of affect and motivation.

Entities:  

Mesh:

Year:  1985        PMID: 4035304     DOI: 10.1093/schbul/11.3.409

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  42 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

2.  [Identification of possible cognizance parameters of "mimic disintegration" in schizophrenia using facial electromyography].

Authors:  K Wolf; S Köppel; R Mass; D Naber
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 3.  Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

Authors:  S R Kay
Journal:  Psychiatr Q       Date:  1990

4.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 5.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

6.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

Review 7.  Neuropsychology and psychopathology: a progress report.

Authors:  P Flor-Henry
Journal:  Neuropsychol Rev       Date:  1990-06       Impact factor: 7.444

8.  Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study.

Authors:  D M Censits; J D Ragland; R C Gur; R E Gur
Journal:  Schizophr Res       Date:  1997-04-11       Impact factor: 4.939

9.  Positive and negative symptoms in families with schizophrenia.

Authors:  A S Bassett; E J Collins; S E Nuttall; W G Honer
Journal:  Schizophr Res       Date:  1993-12       Impact factor: 4.939

10.  Csf amines and their metabolites in first episode drug naive schizophrenic patients and their correlations with dimensions of schizophrenia.

Authors:  I Anand; T A Sunitha; Sumant Khanna
Journal:  Indian J Psychiatry       Date:  2002-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.